Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

NAT

NAT is an initial hit of NAMPT activator with an EC50 of 5.7 μM and a KD of 379 nM. NAMPT is the rate-limiting enzyme in the NAD salvage pathway, which makes it an attractive target for the research of many diseases associated with NAD exhaustion such as neurodegenerative diseases[1].

Product Specifications

CAS Number

831243-31-3

UNSPSC

12352005

Target

NAMPT

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Neuroscience-Neurodegeneration

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/nat.html

Purity

99.85

Solubility

DMSO : ≥ 100 mg/mL

Smiles

CC(C)(C1=C(C=CC=C1)OCC(NC2=CC=C(C=C2)O)=O)C

Molecular Formula

C18H21NO3

Molecular Weight

299.36

References & Citations

[1]Wang L, et al. Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy [published online ahead of print, 2022 Mar 16]. Eur J Med Chem. 2022;236:114260.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Recombinant Human CCL2 Protein
BRP1173-2 50 µg

Recombinant Human CCL2 Protein

Sign In for Pricing
View Details
Synaptotagmin X Rabbit Polyclonal Antibody (APC)
orb991955 100 µL

Synaptotagmin X Rabbit Polyclonal Antibody (APC)

Sign In for Pricing
View Details
1-Bromo-3-methyl-2-butene (90%)
409257-01 1 g

1-Bromo-3-methyl-2-butene (90%)

Sign In for Pricing
View Details
1-Bromo-3-methyl-2-butene (90%)
409257-02 5 g

1-Bromo-3-methyl-2-butene (90%)

Sign In for Pricing
View Details
Fluralaner Impurity 48
RM-F101048-01 10 mg

Fluralaner Impurity 48

Sign In for Pricing
View Details
Fluralaner Impurity 48
RM-F101048-02 25 mg

Fluralaner Impurity 48

Sign In for Pricing
View Details